Rays of Belief IPO Day 2: GMP Signals 16% Premium as Subscription Rises — Should You Apply?
The Rays of Belief IPO has attracted strong attention from retail investors as bidding entered its second day. The ₹125 crore public issue, backed by the company behind the Mom’s Belief brand, opened for subscription on September 1 and closes on September 3, 2026.
The Rays of Belief IPO subscription status and GMP on Day 2 are giving investors two different but important signals. Retail demand has been particularly strong, while institutional participation remains comparatively limited. Meanwhile, the grey market premium, or GMP, has indicated positive sentiment—but investors should remember that GMP is unofficial and can change sharply before listing.
As of the available Day 2 data, the issue was subscribed about 3.61 times overall, with the retail category subscribed 18.56 times and the NII portion 2.06 times. QIB participation was still minimal at that stage.
Rays of Belief IPO: Key Details Investors Should Know
Rays of Belief is raising approximately ₹125 crore through an IPO consisting entirely of a fresh issue of 52.30 lakh equity shares. There is no offer-for-sale component, meaning the IPO proceeds are intended to go to the company rather than existing shareholders selling their stakes.
The IPO price band has been fixed at ₹227 to ₹239 per share, and investors can apply in lots of 62 shares. At the upper price band, one lot requires an investment of about ₹14,818.
The company is expected to finalise the basis of allotment after the issue closes, with a tentative listing on the BSE and NSE scheduled for September 8, 2026.
What Does the Rays of Belief IPO GMP Indicate?
The grey market premium was reported at around ₹38 per share, which implied a potential premium of roughly 16% over the upper issue price of ₹239.
On a purely mathematical basis, adding the reported GMP to the upper price band suggests an indicative price of around ₹277 per share. However, this should not be treated as a price target or a guaranteed listing level.
The grey market is unofficial and unregulated. GMP can rise, fall or disappear before listing depending on subscription trends, broader market sentiment and investor demand.
For IPO applicants looking only for short-term listing gains, relying entirely on GMP can therefore be risky.
Retail Investors Are Driving the Subscription
The most notable feature of the Rays of Belief IPO so far has been strong retail participation.
The issue had already been subscribed 1.18 times on Day 1, with the retail category receiving substantially stronger demand than other investor categories. By Day 2, the overall subscription had climbed to approximately 3.61 times, while retail subscription reached 18.56 times, according to the available exchange-linked data.
Strong retail demand can indicate enthusiasm for an IPO, but it does not automatically mean that the company's valuation is attractive or that the stock will deliver strong long-term returns.
For investors, the composition of demand matters. A healthy balance between retail, high-net-worth and institutional participation can provide a broader picture of market interest.
What Does Rays of Belief Do?
Rays of Belief operates in the intervention and care space for children with neurodevelopmental disorders through its Mom’s Belief brand. Its services address conditions including autism spectrum disorder, ADHD, Down syndrome, cerebral palsy, intellectual disabilities and developmental delays.
The company has been expanding its network in India and has also been pursuing growth in the US market.
This gives the company exposure to a specialised healthcare and intervention segment where awareness and demand for structured developmental services may continue to increase.
However, expansion in this sector also requires execution. Opening new centres, hiring specialised professionals and building a sustainable presence across geographies can involve significant costs.
How Will the IPO Money Be Used?
Because this is a fresh issue, the use of proceeds is an important part of the investment case.
Rays of Belief plans to use funds for expansion, including the establishment of new centres and related technology infrastructure. The company has also earmarked funds for lease-related expenses, investment in its US subsidiary, brand awareness and potential inorganic growth opportunities.
According to available IPO disclosures and reports, the company has outlined plans for significant network expansion over the coming years.
That creates a clear growth opportunity—but it also raises the execution risk. Rapid expansion can increase revenue potential, yet new centres must reach sufficient utilisation to justify the upfront investment.
Growth Opportunity vs Key Risks
The investment case appears to rest largely on the company's ability to scale its specialised care network.
Potential positives
Growing awareness around neurodevelopmental intervention services.
Expansion of the Mom’s Belief network in India.
International growth ambitions, including the US market.
IPO proceeds being directed toward expansion rather than an offer-for-sale.
Strong retail subscription and positive grey market sentiment during the issue period.
Key risks
The company has a relatively limited profitability track record, and reports on the IPO have highlighted negative operating cash flow in FY26. Aggressive expansion could also place additional pressure on cash requirements and execution capabilities.
Another challenge for investors is valuation comparison. The lack of directly comparable listed peers can make it harder to judge whether the IPO price adequately reflects the company's growth prospects and financial risks.
The strong GMP should also be viewed carefully. A grey market premium reflects sentiment, not guaranteed future performance.
Should You Apply for the Rays of Belief IPO?
The answer depends on the investor's objective and risk appetite.
For investors focused primarily on listing gains, the reported GMP of around 16% and strong retail demand suggest positive market sentiment. However, GMP is unofficial, and high subscription does not guarantee a profitable listing.
For long-term investors, the more important question is whether Rays of Belief can convert its expansion plans into sustainable revenue growth, stronger profitability and positive cash generation.
The company's presence in a specialised and potentially growing segment provides an interesting long-term opportunity. At the same time, investors should consider profitability, operating cash flow, expansion costs and execution risks before applying.
A cautious approach may therefore be more appropriate than applying solely because of the GMP.
What Investors Should Watch Before Listing
With the IPO closing on September 3, investors should monitor:
Final subscription figures across retail, NII and QIB categories.
Any significant change in the grey market premium.
The company's expansion and centre rollout plans.
Future profitability and operating cash-flow performance.
Broader stock market conditions ahead of the tentative September 8 listing.
The final day of subscription may provide a clearer picture of institutional demand, which will be particularly important given the limited QIB participation reported during the earlier stages.
Conclusion
The Rays of Belief IPO has generated strong interest from retail investors, with Day 2 subscription figures showing a sharp increase from the 1.18 times subscription recorded on Day 1. The reported GMP of around 16% also points to positive pre-listing sentiment.
However, the investment decision should not be based on GMP alone. The company's specialised business model and expansion potential are positives, but profitability, cash-flow pressure and execution risks deserve equal attention.
For investors, the key development to watch is the final subscription mix and how the company performs after listing as it spends IPO proceeds on expansion.
Follow AIViralHub for more IPO, stock market, business and personal finance updates.
Disclaimer: This article is for informational and educational purposes only and should not be considered investment advice.